• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[反义VEGF165 cDNA与胸苷激酶基因共表达对骨肉瘤的体外抑制作用]

[Suppression of osteosarcoma in vitro by coexpression of antisense VEGF165 cDNA and thymidine kinase gene].

作者信息

Wang Yan, Qiao Hui, Peng Ting-Sheng, Li Yang, Zhang Meng, Liang Hui-Zhen, Qiu Ju-Shi

机构信息

Department of Pathology, Sun Yat-sen Medical College, Sun Yat-sen University, Guangzhou 510089, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2007 Mar;36(3):190-5.

PMID:17535687
Abstract

OBJECTIVE

To investigate the effect of VEGF expression in osteosarcoma cell line and the target killing effect of HSV1-TK/GCV system on transfected osteosarcoma cells under hypoxia conditions.

METHODS

Eukaryotic expression plasmid with HRE promoter was constructed to express the antisense VEGF165 cDNA and Hygromycin phospho-transferase-thymidine kinase (HyTK) fusion gene. The recombinant vectors were then transfected into osteosarcoma cell line MG63 with lipofectin mediated gene transfer methods. PCR and RT-PCR were used to confirm the presence and expression of TK gene. The sensitivity of transfected cells to GCV and "bystander effect (BSE)" of HSV1-TK/GCV system under normoxia or hypoxia conditions were measured by MTT assay and mixed co-culture experiment. The expression of VEGF protein was detected by ELISA under hypoxia condition. Cell cycle phase distribution was determined by flow cytometry. In addition, electromicroscopy was used to document ultrastructural alterations.

RESULTS

The eukaryotic expression vector pBI-HRE-AsVEGF165 -HyTK was constructed successfully. The transfected cell line MG63TV was established and confirmed by PCR and RT-PCR of the presence of transgene and its mRNA expression. GCV was toxic to transfected cells in a concentration-dependent manner. The sensitivity to GCV toxicity was 100 times higher under hypoxia condition than that under normoxic condition. The mixed culture experiments showed that the "bystander effect" was enhanced significantly under hypoxia condition. VEGF expression of transgene cells under hypoxia condition decreased 50% compared to that of normal condition. Under hypoxia and GCV, DNA synthesis of MG63TV cells was inhibited along with an increase of cells at G0 approximately G1 phase, apoptosis and necrosis.

CONCLUSIONS

Antisense VEGF expression driven by HRE promoter in combination with hypoxia can provide a target inhibition of VEGF expression in human osteosarcoma cells, with an enhanced selective killing effect and BSE of the HSV-TK/GCV system. The double-gene co-expression system in study provides experimental basis for therapy against osteosarcoma by a synchronous antiangiogenic and suicide gene approach.

摘要

目的

探讨缺氧条件下血管内皮生长因子(VEGF)在骨肉瘤细胞系中的表达情况以及单纯疱疹病毒I型胸苷激酶/丙氧鸟苷(HSV1-TK/GCV)系统对转染骨肉瘤细胞的靶向杀伤作用。

方法

构建含缺氧反应元件(HRE)启动子的真核表达质粒,以表达反义VEGF165 cDNA及潮霉素磷酸转移酶-胸苷激酶(HyTK)融合基因。然后用脂质体介导的基因转移方法将重组载体转染至骨肉瘤细胞系MG63。采用聚合酶链反应(PCR)及逆转录-聚合酶链反应(RT-PCR)证实TK基因的存在及表达。通过噻唑蓝(MTT)比色法及混合共培养实验检测转染细胞在常氧或缺氧条件下对GCV的敏感性及HSV1-TK/GCV系统的“旁观者效应(BSE)”。采用酶联免疫吸附测定(ELISA)法检测缺氧条件下VEGF蛋白的表达。通过流式细胞术检测细胞周期分布。此外,用电子显微镜记录超微结构改变。

结果

成功构建真核表达载体pBI-HRE-AsVEGF165 -HyTK。通过PCR及RT-PCR证实转基因及其mRNA表达,从而建立了转染细胞系MG63TV。GCV对转染细胞具有浓度依赖性毒性。缺氧条件下对GCV毒性的敏感性比常氧条件下高100倍。混合培养实验表明,缺氧条件下“旁观者效应”显著增强。缺氧条件下转基因细胞的VEGF表达较正常条件下降50%。在缺氧及GCV作用下,MG63TV细胞的DNA合成受到抑制,同时处于G0~G1期的细胞增多,出现凋亡及坏死。

结论

由HRE启动子驱动的反义VEGF表达联合缺氧可靶向抑制人骨肉瘤细胞中的VEGF表达,增强HSV-TK/GCV系统的选择性杀伤作用及旁观者效应。本研究中的双基因共表达系统为骨肉瘤的同步抗血管生成及自杀基因治疗方法提供了实验依据。

相似文献

1
[Suppression of osteosarcoma in vitro by coexpression of antisense VEGF165 cDNA and thymidine kinase gene].[反义VEGF165 cDNA与胸苷激酶基因共表达对骨肉瘤的体外抑制作用]
Zhonghua Bing Li Xue Za Zhi. 2007 Mar;36(3):190-5.
2
[Targeted inhibition of vascular endothelial growth factor (VEGF) expression in human osteosarcoma cell line by antisense VEGF165 cDNA promoted by hypoxia reaction element].缺氧反应元件介导的反义VEGF165 cDNA对人骨肉瘤细胞系血管内皮生长因子(VEGF)表达的靶向抑制作用
Zhonghua Bing Li Xue Za Zhi. 2005 Sep;34(9):588-91.
3
[Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].[缺氧反应元件调控的单纯疱疹病毒胸苷激酶系统增强更昔洛韦在缺氧条件下对尤因肉瘤细胞系的杀伤作用]
Zhonghua Er Ke Za Zhi. 2006 Aug;44(8):616-20.
4
[HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].[使用缺氧/辐射双敏感启动子的肺腺癌异种移植瘤单纯疱疹病毒胸苷激酶基因治疗]
Ai Zheng. 2004 Jul;23(7):788-93.
5
Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.血管内皮生长因子基因启动子驱动的自杀基因对缺氧肿瘤细胞的治疗效果。
Cancer Res. 2000 Jun 1;60(11):2936-41.
6
[Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].[单纯疱疹病毒胸苷激酶/更昔洛韦方法介导的旁观者效应在前列腺癌细胞上的作用及其调控]
Zhonghua Yi Xue Za Zhi. 2002 Nov 10;82(21):1484-7.
7
[Experimental research in vitro of TK/GCV system for osteosarcoma MG-63 cell damage].骨肉瘤MG-63细胞损伤的TK/GCV系统体外实验研究
Zhongguo Gu Shang. 2014 Mar;27(3):240-3.
8
[An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].[人端粒酶逆转录酶启动子驱动单纯疱疹病毒胸苷激酶基因靶向肺癌自杀基因治疗的实验研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):701-5.
9
[In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].人端粒酶逆转录酶基因启动子调控的胞嘧啶脱氨酶-胸苷激酶融合自杀基因治疗系统对卵巢癌细胞的体外治疗
Zhonghua Fu Chan Ke Za Zhi. 2004 Jun;39(6):390-5.
10
[A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].人端粒酶催化亚基启动子驱动的Hsv-tk/GCV对人肺癌细胞A549的选择性杀伤作用研究
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Apr;24(2):148-52.